These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28938506)

  • 1. [Central Aortic Blood Pressure: Important Parameter in Diagnosis and Therapy].
    Middeke M
    Dtsch Med Wochenschr; 2017 Sep; 142(19):1430-1436. PubMed ID: 28938506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discordant effects of beta-blockade on central aortic systolic and brachial systolic blood pressure: considerations beyond the cuff.
    Epstein BJ; Anderson S
    Pharmacotherapy; 2007 Sep; 27(9):1322-33. PubMed ID: 17723086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between radial and central arterial pulse wave and evaluation of central aortic pressure using the radial arterial pulse wave.
    Takazawa K; Kobayashi H; Shindo N; Tanaka N; Yamashina A
    Hypertens Res; 2007 Mar; 30(3):219-28. PubMed ID: 17510503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central blood pressure: current evidence and clinical importance.
    McEniery CM; Cockcroft JR; Roman MJ; Franklin SS; Wilkinson IB
    Eur Heart J; 2014 Jul; 35(26):1719-25. PubMed ID: 24459197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Central Blood Pressure Monitoring in the Management of Hypertension.
    Ochoa A; Patarroyo-Aponte G; Rahman M
    Curr Cardiol Rep; 2018 Apr; 20(6):41. PubMed ID: 29675613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central aortic blood pressure assessment and cardiovascular risk.
    Ram CV
    Indian Heart J; 2010; 62(1):13-6. PubMed ID: 21180028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central aortic pressure and clinical outcomes.
    Williams B; Lacy PS
    J Hypertens; 2009 Jun; 27(6):1123-5. PubMed ID: 19454902
    [No Abstract]   [Full Text] [Related]  

  • 8. Different influences on central and peripheral pulse pressure, aortic wave reflections and pulse wave velocity of three different types of antihypertensive drugs.
    Polónia J; Barbosa L; Silva JA; Maldonado J
    Rev Port Cardiol; 2003 Dec; 22(12):1485-92. PubMed ID: 15008064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From 'optimal' to 'borderline' blood pressure in subjects under chronic antihypertensive therapy.
    Vergnaud AC; Protogerou AD; Blacher J; Safar ME
    J Hypertens; 2008 Jan; 26(1):138-44. PubMed ID: 18090551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of antihypertensive drugs on central blood pressure in humans: a preliminary observation.
    Agnoletti D; Zhang Y; Borghi C; Blacher J; Safar ME
    Am J Hypertens; 2013 Aug; 26(8):1045-52. PubMed ID: 23736112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical measurement of arterial stiffness obtained from noninvasive pressure waveforms.
    Nichols WW
    Am J Hypertens; 2005 Jan; 18(1 Pt 2):3S-10S. PubMed ID: 15683725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Williams B; Lacy PS; Thom SM; Cruickshank K; Stanton A; Collier D; Hughes AD; Thurston H; O'Rourke M; ; ;
    Circulation; 2006 Mar; 113(9):1213-25. PubMed ID: 16476843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central blood pressure as an index of antihypertensive control: determinants and potential value.
    Trudeau L
    Can J Cardiol; 2014 May; 30(5 Suppl):S23-8. PubMed ID: 24750979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central pressure: variability and impact of cardiovascular risk factors: the Anglo-Cardiff Collaborative Trial II.
    McEniery CM; Yasmin ; McDonnell B; Munnery M; Wallace SM; Rowe CV; Cockcroft JR; Wilkinson IB;
    Hypertension; 2008 Jun; 51(6):1476-82. PubMed ID: 18426997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brachial-brachial index of systolic blood pressure in the patients under anti-hypertensive therapy.
    Sun H; Li P; Su H; Wang W; Wang J; Hu W; Li J; Liu Y; Cheng X
    Int J Cardiol; 2014 Jul; 174(3):802-4. PubMed ID: 24814541
    [No Abstract]   [Full Text] [Related]  

  • 16. Central blood pressures: do we need them in the management of cardiovascular disease? Is it a feasible therapeutic target?
    Protogerou AD; Papaioannou TG; Blacher J; Papamichael CM; Lekakis JP; Safar ME
    J Hypertens; 2007 Feb; 25(2):265-72. PubMed ID: 17211229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-invasive central blood pressure measurement: how and why?].
    Pasche A; Feihl F; Liaudet L; Waeber B
    Praxis (Bern 1994); 2007 Jul; 96(29-30):1137-40. PubMed ID: 17691449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brachial arterial pressure to assess cardiovascular structural damage: an overview and lessons from clinical trials.
    London GM
    J Nephrol; 2008; 21(1):23-31. PubMed ID: 18264933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraaortic pulse pressure amplification in subjects at high coronary risk.
    Temmar M; Jankowski P; Peltier M; Mouquet V; Debicka-Dabrowska D; Hamida F; Kawecka-Jaszcz K; Safar ME
    Hypertension; 2010 Feb; 55(2):327-32. PubMed ID: 20048195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of the N-point moving average method for brachial pressure waveform-derived estimation of central aortic systolic pressure.
    Shih YT; Cheng HM; Sung SH; Hu WC; Chen CH
    Hypertension; 2014 Apr; 63(4):865-70. PubMed ID: 24420554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.